by inovait.ca | Oct 26, 2021 | Uncategorized
A technique has been developed that could revolutionise the treatment of brain cancers and neurodegenerative diseases by temporarily allowing drugs and other substances to cross the blood brain barrier – a structure that separates the brain’s blood vessels from the... by inovait.ca | Oct 7, 2021 | Uncategorized
MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing... by inovait.ca | Aug 25, 2021 | Uncategorized
TORONTO, AUGUST 25, 2021 – Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure (LAAC) procedure. The new solution includes the world’s first 3-in-1 radiofrequency (RF)...